Los Angeles Capital Management
TEVA icon

Los Angeles Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Los Angeles Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-123,714
Closed -$1.29M – 1221
2023
Q4 		$1.29M Sell
123,714
-170,449
-58% -$1.59M ﹤0.01% 593
2023
Q3 		$3M Buy
+294,163
New +$2.74M 0.01% 378
2023
Q1 		– Sell
-41,929
Closed -$382K – 1295
2022
Q4 		$382K Sell
41,929
-34,955
-45% -$305K ﹤0.01% 964
2022
Q3 		$620K Buy
76,884
+3,943
+5% +$34.9K ﹤0.01% 856
2022
Q2 		$549K Buy
+72,941
New +$635K ﹤0.01% 935
2020
Q3 		– Sell
-46,769
Closed -$577K – 1524
2020
Q2 		$577K Sell
46,769
-1,083
-2% -$12.2K ﹤0.01% 1056
2020
Q1 		$430K Sell
47,852
-80,079
-63% -$820K ﹤0.01% 953
2019
Q4 		$1.25M Sell
127,931
-108,269
-46% -$967K 0.01% 769
2019
Q3 		$1.63M Sell
236,200
-250,400
-51% -$1.92M 0.01% 681
2019
Q2 		$4.49M Buy
486,600
+51,300
+12% +$619K 0.02% 457
2019
Q1 		$6.83M Sell
435,300
-215,900
-33% -$3.81M 0.04% 376
2018
Q4 		$10M Buy
651,200
+598,900
+1,145% +$12.3M 0.06% 264
2018
Q3 		$1.13M Buy
52,300
+11,400
+28% +$265K 0.01% 831
2018
Q2 		$995K Buy
+40,900
New +$834K 0.01% 906
2018
Q1 		– Sell
-126,981
Closed -$2.41M – 1414
2017
Q4 		$2.41M Sell
126,981
-179,735
-59% -$2.7M 0.01% 616
2017
Q3 		$5.4M Buy
306,716
+109,239
+55% +$2.46M 0.03% 418
2017
Q2 		$6.56M Buy
+197,477
New +$6.11M 0.04% 393

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Los Angeles Capital Management's TEVA Position: Q1 2024 in Review

Los Angeles Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 123,714 shares — an estimated $1.29M sold.

Los Angeles Capital Management first reported a position in TEVA in Q2 2017 and held it in 17 quarters. The position peaked at $10M in Q4 2018. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Los Angeles Capital Management reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Los Angeles Capital Management sold 123,714 Teva Pharmaceuticals shares in Q1 2024, an estimated $1.29M.
  • Los Angeles Capital Management first reported a position in Teva Pharmaceuticals in Q2 2017 and held it in 17 quarters.
  • Los Angeles Capital Management's Teva Pharmaceuticals position peaked at $10M in Q4 2018.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Los Angeles Capital Management's 13F filing for Q1 2024, filed 5 Apr 2024.